
    
      We aim to conduct "A Phase III Randomized Trial of Maintenance Chemotherapy in
      High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage" to evaluate the
      effectiveness and compliance of gemicitabine as maintenance chemotherapy in N3 nasopharyngeal
      carcinoma.
    
  